1. Home
  2. RCKT vs LEG Comparison

RCKT vs LEG Comparison

Compare RCKT & LEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • LEG
  • Stock Information
  • Founded
  • RCKT 1999
  • LEG 1883
  • Country
  • RCKT United States
  • LEG United States
  • Employees
  • RCKT N/A
  • LEG N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • LEG Home Furnishings
  • Sector
  • RCKT Health Care
  • LEG Consumer Discretionary
  • Exchange
  • RCKT Nasdaq
  • LEG Nasdaq
  • Market Cap
  • RCKT 764.5M
  • LEG 885.3M
  • IPO Year
  • RCKT N/A
  • LEG N/A
  • Fundamental
  • Price
  • RCKT $7.18
  • LEG $9.28
  • Analyst Decision
  • RCKT Strong Buy
  • LEG Hold
  • Analyst Count
  • RCKT 10
  • LEG 4
  • Target Price
  • RCKT $44.10
  • LEG $10.50
  • AVG Volume (30 Days)
  • RCKT 3.2M
  • LEG 3.3M
  • Earning Date
  • RCKT 05-08-2025
  • LEG 04-28-2025
  • Dividend Yield
  • RCKT N/A
  • LEG 2.14%
  • EPS Growth
  • RCKT N/A
  • LEG N/A
  • EPS
  • RCKT N/A
  • LEG N/A
  • Revenue
  • RCKT N/A
  • LEG $4,308,800,000.00
  • Revenue This Year
  • RCKT N/A
  • LEG N/A
  • Revenue Next Year
  • RCKT N/A
  • LEG $1.12
  • P/E Ratio
  • RCKT N/A
  • LEG N/A
  • Revenue Growth
  • RCKT N/A
  • LEG N/A
  • 52 Week Low
  • RCKT $4.55
  • LEG $6.48
  • 52 Week High
  • RCKT $26.98
  • LEG $14.30
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 46.92
  • LEG 63.97
  • Support Level
  • RCKT $6.21
  • LEG $9.05
  • Resistance Level
  • RCKT $8.26
  • LEG $9.92
  • Average True Range (ATR)
  • RCKT 0.58
  • LEG 0.35
  • MACD
  • RCKT 0.03
  • LEG 0.21
  • Stochastic Oscillator
  • RCKT 28.05
  • LEG 80.03

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About LEG Leggett & Platt Incorporated

Leggett & Platt Inc designs and produces engineered components and products found in homes and automobiles. It operates its business through three segments namely Bedding Products, Specialized Products, and Furniture, Flooring, and Textile Products. It generates the majority of its revenue from Bedding Products. Serving a broad suite of customers around the world, Leggett & Platt's products include bedding components, automotive seat support, and lumbar systems, specialty bedding foam and private label finished mattresses, components for home furniture, and work furniture, flooring underlayment, adjustable beds, and various other products.

Share on Social Networks: